Operations

IQVIA Announces Pricing of Secondary Public Offering

May 22, 2018

DANBURY, Conn., & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 10,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, […]

TEDOR Pharma Announces Recapitalization and New Management

May 22, 2018

CUMBERLAND, R.I., May 16, 2018 /PRNewswire/ — TEDOR Pharma, Inc., a full-service, end-to-end, contract development and manufacturing company (CDMO) founded in 2001, today announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc.   DORA Ventures is a newly formed investment vehicle, owned and controlled by Laura […]

Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)

May 22, 2018

– Plans to Seek FDA Guidance for Potential Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) Indication PALO ALTO, Calif., May 16, 2018 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that it has expanded its licensing agreement with Merck, known as MSD outside […]

Roivant Expands Senior Leadership with Key Hires

May 22, 2018

– Dr. Sam Azoulay, former SVP and Chief Medical Officer at Pfizer Essential Health, joins as Chief Medical Officer – Adele Gulfo, former President and General Manager for US Primary Care at Pfizer, joins as Chief of Commercial Development BASEL, Switzerland and NEW YORK, May 16, 2018 /PRNewswire/ — Roivant Sciences today announced the expansion […]

Sublimity Therapeutics Closes US$64 Million Financing to Fund Development of New Oral Ulcerative Colitis Drug Candidate

May 22, 2018

Orally delivered soluble formulation of cyclosporine represents promising new treatment option for patients with moderate to severe ulcerative colitis DUBLIN, Ireland, May 22, 2018 (GLOBE NEWSWIRE) — Sublimity Therapeutics Limited (formerly Sigmoid Pharma Limited), a specialty pharmaceutical company focused on the treatment of ulcerative colitis, today announced it has completed a US$64 million financing to […]

Tjoapack and Photocure sign agreement

May 22, 2018

Global contract packaging organisation, Tjoapack, has signed a five-year agreement with Photocure for the packaging of its proprietary bladder cancer detection products. Hexvix®/Cysview® is a drug that is selectively taken up by cancer cells in the bladder making them glow bright pink during Blue Light Cystoscopy (BLCTM).  BLCTM with Hexvix®/Cysview® improves the detection of tumours […]

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

May 22, 2018

WCG expands global clinical research support presence WCG™ (WIRB-Copernicus Group®) Clinical Services Division, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company’s new office in Tokyo, Japan. WCG’s expanded presence in the Asia-Pacific region will strengthen its ability to support increasingly […]

Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research Collaboration

May 22, 2018

EVANSTON, IL – May 22, 2018 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Allergan plc (NYSE: AGN) has exercised its option to acquire drug candidate AGN-241751, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor modulator. Aptinyx discovered AGN-241751 utilizing its proprietary chemistry platform and the compound was selected […]

Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations

May 22, 2018

— Robert Discordia, Ph.D., named Vice President, Pharmaceutical Development & Manufacturing — — Ross Lobell named Vice President, Regulatory Affairs — Norwood, MA, May 22, 2018 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to […]

Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action

May 22, 2018

PITTSBURGH, May 22, 2018 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive disorders, today announced the receipt of two multi-year grants from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) totaling […]

PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner

May 22, 2018

Collaboration to drive innovation across health care ecosystem WILMINGTON, N.C., May 22, 2018 – Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS) initiative as a strategic partner. PPD is the first contract […]

Longeveron Receives Tedco Grant To Fund Stem Cell Research

May 22, 2018

Grant will be applied to clinical trials studying stem cells to boost Flu vaccine immune response in older patients MIAMI – May 22, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related conditions, announced that it has received a $750,000 grant from the Maryland Technology Development Corporation (TEDCO). Longeveron will […]

Certara’s Analytica Laser Launches Market Access Radar Providing Biopharma and Medical Device Companies with Breaking News on Access to Health Technologies Globally

May 22, 2018

Analytica Laser’s population health intelligence experts monitor, compile and deliver relevant and up-to-the minute global market access news via newsletter and web portal Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of Analytica Laser’s Market Access Radar™, a three times weekly market access […]

Human resources’ImmusanT Expands Management Team to Strengthen Financial Operations and Accelerate Clinical Development

May 21, 2018

— Kristin M. Neff joins as VP, Clinical Operations and Project Management – — Joyce A. Pinkham joins as VP, Program Management – — Jonathan Yeadon joins as Director, Finance – CAMBRIDGE, Mass.–(BUSINESS WIRE)–ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy (ESIT) platform to translate and deliver first-in-class peptide-based immune therapies […]

Cidara Therapeutics and Rutgers University Awarded $5.5 Million Grant from NIH to Support Development of Novel Immunotherapy Agents Targeting Multi-drug Resistant Gram-negative Bacterial Infections

May 21, 2018

New Partnership to Jointly Conduct Preclinical Development of Cidara’s Cloudbreak Antibody-Drug Conjugates SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it and Rutgers University have been awarded a five-year, $5.5 million partnership grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of […]

Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology

May 21, 2018

INDIANAPOLIS–(BUSINESS WIRE)–Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. Scioto Biosciences announced the closing of their Series A financing for development of innovative therapies to transform […]

PDL BioPharma Names Dr. Jill Jene Vice President, Business Development

May 21, 2018

INCLINE VILLAGE, Nev., May 21, 2018 /PRNewswire/ — PDL BioPharma, Inc. (“PDL” or “the Company”) (NASDAQ: PDLI) announces the appointment of Jill M. Jene, Ph.D. as Vice President, Business Development. Dr. Jene will lead the efforts to add healthcare assets to PDL’s portfolio of products and companies. She will report to PDL President, Dominique Monnet. […]

Mundipharma and Endoceutics to Exclusively License Intrarosa™ (Prasterone) in MEA Region

May 21, 2018

DUBAI, UAE, May 20, 2018 /PRNewswire/ — A unique non-estrogen prescription therapy, Intrarosa™, has been approved by the US Food and Drug Administration (FDA) and by the European Medical Agency (EMA), for the treatment of the most bothersome symptom of vulvovaginal atrophy, due to menopause, known as dyspareunia. Mundipharma has been granted the commercial rights […]

GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines

May 21, 2018

GC Pharma, IDRI and MIBR Bringing Together to Develop Innovative Vaccines Curevo Vaccine CI Curevo Vaccine CI YONGIN, South Korea, May 20, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. (“Curevo”). The newly established Seattle-based company’s goal is […]

GTx Updates Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at 2018 AUA Annual Meeting

May 21, 2018

Updated patient durability results from proof-of-concept trial presented; reductions in incontinence episodes continue to be sustained for up to 7 months following completion of enobosarm treatment Top-line results from ASTRID, an ongoing Phase 2 placebo-controlled clinical trial, are expected early in the fourth quarter of 2018 MEMPHIS, Tenn.–(BUSINESS WIRE)–GTx, Inc. (Nasdaq: GTXI) today released additional […]

Rain Therapeutics Closes $18 Million Series A Financing

May 21, 2018

FREMONT, Calif., May 21, 2018 (GLOBE NEWSWIRE) — Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on biomarker-driven, small molecule therapeutics for patients with cancer, today announced the closing of a tranched Series A financing of $18.4 million. The financing was led by San Francisco-based, Biotechnology Value Fund (BVF) and followed by Perceptive […]

Akari Therapeutics Receives Notice Related to Delay in 20-F Filing

May 21, 2018

NEW YORK and LONDON, May 21, 2018 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases, today announced that as a result of its inability to timely file its Annual Report on Form 20-F for the year ended […]

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

May 21, 2018

– Commercialization Expertise Beneficial as SetPoint Advances its Clinical Program – Valencia, CA – May 21, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Shah has more than a decade of experience […]

FEEDBACK